Breathtec Biomedical Inc Stock Deutsche Boerse AG
Equities
Biotechnology & Medical Research
Sales 2022 | - | Sales 2023 | - | Capitalization | 2.6M 2.4M 3.55M |
---|---|---|---|---|---|
Net income 2022 | -6M -5.53M -8.19M | Net income 2023 | -6M -5.53M -8.19M | EV / Sales 2022 | - |
Net cash position 2022 | 1.41M 1.3M 1.92M | Net cash position 2023 | 125K 115K 171K | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.55
x | P/E ratio 2023 |
-0.37
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.2% |
Managers | Title | Age | Since |
---|---|---|---|
Chris Moreau
CEO | Chief Executive Officer | 59 | 18-02-28 |
James Kinley
DFI | Director of Finance/CFO | 45 | 21-11-30 |
Chief Operating Officer | 41 | 21-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Harry Bloomfield
CHM | Chairman | 79 | 21-09-07 |
Chris Moreau
CEO | Chief Executive Officer | 59 | 18-02-28 |
Mark Williams
BRD | Director/Board Member | 52 | 21-09-21 |
1st Jan change | Capi. | |
---|---|---|
+7.64% | 115B | |
+12.74% | 107B | |
-13.27% | 22.31B | |
-3.99% | 21.6B | |
-6.19% | 18.23B | |
-39.93% | 17.62B | |
+6.85% | 14.26B | |
+32.78% | 12.37B | |
-28.20% | 8.28B |